Bio-Techne Corp (TECH)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | HIPPEL, JAMES | CFO | Restricted Stock Units | Acquisition | 22,438 | 0 |
| Aug 17, 2026 | BOHNEN, SHANE | SVP - General Counsel | Restricted Stock Units | Acquisition | 18,432 | 0 |
| Aug 17, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Restricted Stock Units | Acquisition | 57,590 | 0 |
| Aug 17, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Restricted Stock Units | Acquisition | 8,702 | 0 |
| Aug 17, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Restricted Stock Units | Acquisition | 14,140 | 0 |
| Aug 17, 2026 | GEIST, WILLIAM | PRESIDENT, PROTEIN SCIENCES | Restricted Stock Units | Acquisition | 23,985 | 0 |
| Aug 17, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Restricted Stock Units | Acquisition | 93,582 | 0 |
| Aug 17, 2026 | BOHNEN, SHANE | SVP - General Counsel | Restricted Stock Units | Acquisition | 11,344 | 0 |
| Aug 17, 2026 | HERR, AMY E. | Director | Restricted Stock Units | Acquisition | 1,381 | 0 |
| Aug 17, 2026 | HIPPEL, JAMES | CFO | Restricted Stock Units | Acquisition | 36,459 | 0 |
| Aug 17, 2026 | GEIST, WILLIAM | PRESIDENT, PROTEIN SCIENCES | Restricted Stock Units | Acquisition | 14,762 | 0 |
| Aug 15, 2026 | GEIST, WILLIAM | PRESIDENT, PROTEIN SCIENCES | Restricted Stock Units | Disposal | 2,623 | 0 |
| Aug 15, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Restricted Stock Units | Disposal | 8,543 | 0 |
| Aug 15, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Performance Stock Options (Right to Buy) | Disposal | 22,389 | 0 |
| Aug 15, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Common Stock | Acquisition | 21,470 | 0 |
| Aug 15, 2026 | HIPPEL, JAMES | CFO | Performance Restricted Stock Units | Disposal | 12,999 | 0 |
| Aug 15, 2026 | GEIST, WILLIAM | PRESIDENT, PROTEIN SCIENCES | Performance Restricted Stock Units | Disposal | 567 | 0 |
| Aug 15, 2026 | BOHNEN, SHANE | SVP - General Counsel | Performance Restricted Stock Units | Disposal | 4,502 | 0 |
| Aug 15, 2026 | GEIST, WILLIAM | PRESIDENT, PROTEIN SCIENCES | Performance Restricted Stock Units | Disposal | 8,507 | 0 |
| Aug 15, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Performance Restricted Stock Units | Disposal | 8,319 | 0 |
| Aug 15, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Performance Restricted Stock Units | Disposal | 554 | 0 |
| Aug 15, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Performance Restricted Stock Units | Disposal | 588 | 0 |
| Aug 15, 2026 | HIPPEL, JAMES | CFO | Restricted Stock Units | Disposal | 4,010 | 0 |
| Aug 15, 2026 | BOHNEN, SHANE | SVP - General Counsel | Restricted Stock Units | Disposal | 49 | 0 |
| Aug 15, 2026 | BOHNEN, SHANE | SVP - General Counsel | Common Stock | Disposal | 1,343 | 72.4 |
| Aug 15, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Performance Restricted Stock Units | Disposal | 8,835 | 0 |
| Aug 15, 2026 | HIPPEL, JAMES | CFO | Restricted Stock Units | Disposal | 4,903 | 0 |
| Aug 15, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Restricted Stock Units | Disposal | 1,379 | 0 |
| Aug 15, 2026 | HERR, AMY E. | Director | Common Stock | Acquisition | 589 | 0 |
| Aug 15, 2026 | BOHNEN, SHANE | SVP - General Counsel | Common Stock | Acquisition | 4,350 | 0 |
| Aug 15, 2026 | BOHNEN, SHANE | SVP - General Counsel | Restricted Stock Units | Disposal | 1,669 | 0 |
| Aug 15, 2026 | BOHNEN, SHANE | SVP - General Counsel | Performance Restricted Stock Units | Disposal | 300 | 0 |
| Aug 15, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Restricted Stock Units | Disposal | 2,176 | 0 |
| Aug 15, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Restricted Stock Units | Disposal | 1,868 | 0 |
| Aug 15, 2026 | HIPPEL, JAMES | CFO | Common Stock | Disposal | 4,310 | 72.4 |
| Aug 15, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Restricted Stock Units | Disposal | 11,785 | 0 |
| Aug 15, 2026 | HERR, AMY E. | Director | Restricted Stock Units | Disposal | 311 | 0 |
| Aug 15, 2026 | HERR, AMY E. | Director | Restricted Stock Units | Disposal | 118 | 0 |
| Aug 15, 2026 | HERR, AMY E. | Director | Restricted Stock Units | Disposal | 160 | 0 |
| Aug 15, 2026 | BOHNEN, SHANE | SVP - General Counsel | Restricted Stock Units | Disposal | 2,332 | 0 |
| Aug 15, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Common Stock | Disposal | 1,947 | 72.4 |
| Aug 15, 2026 | GEIST, WILLIAM | PRESIDENT, PROTEIN SCIENCES | Common Stock | Acquisition | 6,416 | 0 |
| Aug 15, 2026 | GEIST, WILLIAM | PRESIDENT, PROTEIN SCIENCES | Common Stock | Disposal | 1,976 | 72.4 |
| Aug 15, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Performance Stock Options (Right to Buy) | Disposal | 24,324 | 0 |
| Aug 15, 2026 | HIPPEL, JAMES | CFO | Performance Restricted Stock Units | Disposal | 866 | 0 |
| Aug 15, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Common Stock | Disposal | 10,821 | 72.4 |
| Aug 15, 2026 | HIPPEL, JAMES | CFO | Performance Stock Options (Right to Buy) | Disposal | 34,982 | 0 |
| Aug 15, 2026 | GEIST, WILLIAM | PRESIDENT, PROTEIN SCIENCES | Restricted Stock Units | Disposal | 3,226 | 0 |
| Aug 15, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Common Stock | Acquisition | 5,423 | 0 |
| Aug 15, 2026 | HIPPEL, JAMES | CFO | Common Stock | Acquisition | 9,779 | 0 |
| Aug 15, 2026 | BOHNEN, SHANE | SVP - General Counsel | Performance Stock Option (Right to Buy) | Disposal | 12,117 | 0 |
| Aug 15, 2026 | GEIST, WILLIAM | PRESIDENT, PROTEIN SCIENCES | Performance Stock Options (Right to Buy) | Disposal | 22,898 | 0 |
| Aug 15, 2026 | HERR, AMY E. | Director | Common Stock | Disposal | 213 | 72.4 |
| Jul 29, 2026 | HIPPEL, JAMES | CFO | Stock Options (Right to Buy) | Disposal | 62,068 | 0 |
| Jul 29, 2026 | HIPPEL, JAMES | CFO | Common Stock | Disposal | 51,024 | 72.03 |
| Jul 29, 2026 | HIPPEL, JAMES | CFO | Common Stock | Acquisition | 62,068 | 47.6 |
| Jul 28, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Common Stock | Disposal | 28,686 | 72.07 |
| Jul 28, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Stock Option (Right to Buy) | Disposal | 35,000 | 0 |
| Jul 28, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Common Stock | Acquisition | 35,000 | 47.6 |
| Jul 23, 2026 | BOHNEN, SHANE | SVP - General Counsel | Stock Option (Right to Buy) | Disposal | 448 | 0 |
| Jul 23, 2026 | BOHNEN, SHANE | SVP - General Counsel | Common Stock | Disposal | 344 | 71.77 |
| Jul 23, 2026 | BOHNEN, SHANE | SVP - General Counsel | Common Stock | Acquisition | 448 | 47.6 |
| Jun 2, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Common Stock | Acquisition | 600 | |
| Jun 2, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Common Stock | Disposal | 216 | 49.77 |
| Jun 2, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Restricted Stock Units | Disposal | 600 | 0 |
| May 8, 2026 | HERR, AMY E. | Director | Common Stock | Acquisition | 6,636 | 47.6 |
| May 8, 2026 | HERR, AMY E. | Director | Common Stock | Disposal | 6,636 | 48.28 |
| May 8, 2026 | HERR, AMY E. | Director | Stock Option (Right to Buy) | Disposal | 6,636 | 0 |
| May 5, 2026 | HIPPEL, JAMES | CFO | Common Stock | Disposal | 56,955 | 56.68 |
| May 5, 2026 | BOHNEN, SHANE | SVP - General Counsel | Common Stock | Acquisition | 8,400 | 47.6 |
| May 5, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Common Stock | Acquisition | 26,692 | 47.6 |
| May 5, 2026 | BOHNEN, SHANE | SVP - General Counsel | Stock Option (Right to Buy) | Disposal | 8,400 | 0 |
| May 5, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Stock Option (Right to Buy) | Disposal | 26,692 | 0 |
| May 5, 2026 | HIPPEL, JAMES | CFO | Common Stock | Acquisition | 62,000 | 47.6 |
| May 5, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Common Stock | Disposal | 23,951 | 56.68 |
| May 5, 2026 | BOHNEN, SHANE | SVP - General Counsel | Common Stock | Disposal | 7,055 | 56.68 |
| May 5, 2026 | HIPPEL, JAMES | CFO | Stock Options (Right to Buy) | Disposal | 62,000 | 0 |
| May 1, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Restricted Stock Units | Disposal | 794 | 0 |
| May 1, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Common Stock | Disposal | 311 | 55.02 |
| May 1, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Common Stock | Acquisition | 794 | |
| Apr 22, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Stock Option (Right to Buy) | Disposal | 11,344 | 0 |
| Apr 22, 2026 | HIPPEL, JAMES | CFO | Stock Options (Right to Buy) | Disposal | 62,000 | 0 |
| Apr 22, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Common Stock | Acquisition | 11,344 | 0 |
| Apr 22, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Common Stock | Disposal | 1,363 | 58.58 |
| Apr 22, 2026 | HIPPEL, JAMES | CFO | Common Stock | Acquisition | 62,000 | 0 |
| Apr 22, 2026 | HIPPEL, JAMES | CFO | Common Stock | Disposal | 56,097 | 58.58 |
| Apr 14, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Common Stock | Disposal | 32,088 | 58.66 |
| Apr 14, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Common Stock | Acquisition | 36,500 | 0 |
| Apr 14, 2026 | KELDERMAN, KIM | Director, Chief Executive Officer | Stock Option (Right to Buy) | Disposal | 36,500 | 0 |
| Apr 3, 2026 | BOHNEN, SHANE | SVP - General Counsel | Common Stock | Acquisition | 2,259 | 0 |
| Apr 3, 2026 | BOHNEN, SHANE | SVP - General Counsel | Common Stock | Disposal | 740 | 53.13 |
| Apr 3, 2026 | BOHNEN, SHANE | SVP - General Counsel | Restricted Stock Units | Disposal | 2,259 | 0 |
| Mar 2, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Performance Restricted Stock Units | Acquisition | 2,387 | 0 |
| Mar 2, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Stock Option (right to buy) | Acquisition | 1,911 | 0 |
| Mar 2, 2026 | CROUSE, STEVEN C. | President - Diag & Spatial Bi | Restricted Stock Units | Acquisition | 735 | 0 |
| Feb 17, 2026 | HERR, AMY E. | Director | Common Stock | Disposal | 1,976 | 59.105 |
| Feb 3, 2026 | HERR, AMY E. | Director | Restricted Stock Units | Disposal | 38 | 0 |
| Feb 3, 2026 | HERR, AMY E. | Director | Common Stock | Acquisition | 38 | 0 |
| Feb 3, 2026 | HERR, AMY E. | Director | Common Stock | Disposal | 16 | 64.63 |
| Feb 1, 2026 | MCMANUS, MATTHEW | President - Diag & Spatial Bio | Common Stock | Disposal | 1,665 | 64.09 |
| Feb 1, 2026 | MCMANUS, MATTHEW | President - Diag & Spatial Bio | Restricted Stock Units | Disposal | 4,621 | 0 |
| Feb 1, 2026 | MCMANUS, MATTHEW | President - Diag & Spatial Bio | Common Stock | Acquisition | 4,621 | 0 |
| Nov 3, 2025 | GEIST, WILLIAM | PRESIDENT, PROTEIN SCIENCES | Common Stock | Acquisition | 9,911 | 0 |
| Nov 3, 2025 | HIPPEL, JAMES | CFO | Restricted Stock Units | Disposal | 11,545 | 0 |
| Nov 3, 2025 | HIPPEL, JAMES | CFO | Common Stock | Acquisition | 13,159 | 0 |
| Nov 3, 2025 | KELDERMAN, KIM | Director, Chief Executive Officer | Common Stock | Disposal | 2,303 | 62.57 |
| Nov 3, 2025 | GEIST, WILLIAM | PRESIDENT, PROTEIN SCIENCES | Common Stock | Disposal | 4,520 | 62.57 |
| Nov 3, 2025 | GEIST, WILLIAM | PRESIDENT, PROTEIN SCIENCES | Restricted Stock Units | Disposal | 9,911 | 0 |
| Nov 3, 2025 | HIPPEL, JAMES | CFO | Restricted Stock Units | Disposal | 13,159 | 0 |
| Nov 3, 2025 | HIPPEL, JAMES | CFO | Common Stock | Acquisition | 11,545 | 0 |
| Nov 3, 2025 | HIPPEL, JAMES | CFO | Common Stock | Disposal | 11,865 | 62.57 |
| Oct 30, 2025 | KLIMOVSKY, JUDITH V. | Director | Stock Option (Right to Buy) | Acquisition | 3,777 | 0 |
| Oct 30, 2025 | SETH, ALPNA | Director | Common Stock | Acquisition | 1,640 | 0 |
| Oct 30, 2025 | BUSHMAN, JULIE L | Director | Stock Options (Right to Buy) | Acquisition | 3,777 | 0 |
| Oct 30, 2025 | HIGGINS, JOHN L | Director | Stock Options (Right to Buy) | Acquisition | 3,777 | 0 |
| Oct 30, 2025 | KEEGAN, JOSEPH D | Director | Common Stock | Acquisition | 1,640 | 0 |
| Oct 30, 2025 | VESSEY, RUPERT | Director | Stock Options (Right to Buy) | Acquisition | 3,777 | 0 |
| Oct 30, 2025 | HERR, AMY E. | Director | Stock Option (Right to Buy) | Acquisition | 3,777 | 0 |
| Oct 30, 2025 | KLIMOVSKY, JUDITH V. | Director | Common Stock | Acquisition | 1,640 | 0 |
| Oct 30, 2025 | KEEGAN, JOSEPH D | Director | Stock Options (Right to Buy) | Acquisition | 3,777 | 0 |
| Oct 30, 2025 | BAUMGARTNER, ROBERT V | Director | Common Stock | Acquisition | 1,640 | 0 |
| Oct 30, 2025 | HIGGINS, JOHN L | Director | Common Stock | Acquisition | 1,640 | 0 |
| Oct 30, 2025 | BUSHMAN, JULIE L | Director | Common Stock | Acquisition | 1,640 | 0 |
| Oct 30, 2025 | SETH, ALPNA | Director | Stock Options (Right to Buy) | Acquisition | 3,777 | 0 |
| Oct 30, 2025 | BAUMGARTNER, ROBERT V | Director | Stock Options (Right to Buy) | Acquisition | 3,777 | 0 |
| Oct 30, 2025 | HERR, AMY E. | Director | Common Stock | Acquisition | 1,640 | 0 |
| Oct 30, 2025 | VESSEY, RUPERT | Director | Common Stock | Acquisition | 1,640 | 0 |